Trade

with

BioLife Solutions Inc
(NASDAQ: BLFS)
AdChoices
=
2.10
0.00
0.00%
After Hours :
-
-
-

Open

2.10

Previous Close

0.0000

Volume (Avg)

13.98k (76.73k)

Day's Range

2.10-2.10

52Wk Range

0.4600-7.00

Market Cap.

-

Dividend Rate ( Yield )

-

Beta

-0.37

Shares Outstanding

12.03M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 8.95M

    • Net Income

    • -1.08M

    • Market Cap.

    • -

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -28.92

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -0.37

    • Forward P/E

    • -

    • Price/Sales

    • 1.86

    • Price/Book Value

    • 1.87

    • Price/Cash flow

    • -8.38

      • EBITDA

      • -94.87k

      • Return on Capital %

      • -24.53

      • Return on Equity %

      • -608.17

      • Return on Assets %

      • -24.53

      • Book Value/Share

      • 1.11

      • Shares Outstanding

      • 12.03M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -48.00

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 46.58

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 42.11

            • 52.83

            • Pre-Tax Margin

            • -28.92

            • 15.96

            • Net Profit Margin

            • -28.92

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 42.20

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -76.50

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 21.98

              • 1.97

              • Quick Ratio

              • 20.36

              • 1.16

              • Interest Coverage

              • -3.08

              • 10.47

              • Leverage Ratio

              • 1.11

              • 2.38

              • Book Value/Share

              • 1.11

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -6.37

                • 35.09

                • P/E Ratio 5-Year High

                • -73.97

                • 279.76

                • P/E Ratio 5-Year Low

                • -0.87

                • 148.87

                • Price/Sales Ratio

                • 1.84

                • 3.22

                • Price/Book Value

                • 1.85

                • 4.03

                • Price/Cash Flow Ratio

                • -8.38

                • 16.69

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -608.17

                        (-)

                      • 17.93

                        (21.42)

                      • Return on Assets %

                        (5-Year Average)

                      • -24.53

                        (-121.00)

                      • 7.35

                        (9.50)

                      • Return on Capital %

                        (5-Year Average)

                      • -459.08

                        (-)

                      • 10.24

                        (13.59)

                      • Income/Employee

                      • -

                      • 25.65k

                      • Inventory Turnover

                      • 7.05

                      • 2.66

                      • Asset Turnover

                      • 0.85

                      • 0.59

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -285.36k
                      Operating Margin
                      -3.19
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -8.38
                      Ownership

                      Institutional Ownership

                      10.15%

                      Top 10 Institutions

                      16.17%

                      Mutual Fund Ownership

                      1.03%

                      Float

                      51.78%

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • CS (Lux) Biotechnology Equity Fund

                      •  

                        110,274

                      • 0.00

                      • 0.92

                      • Vanguard Extended Market Index Fund

                      •  

                        4,200

                      • 0.00

                      • 0.03

                      • Wilshire Micro-Cap ETF

                      •  

                        2,305

                      • 0.00

                      • 0.02

                      • Vanguard Total Stock Mkt Idx

                      •  

                        1,000

                      • 0.00

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Credit Suisse AG Zurich

                      •  

                        110,274

                      • 0.00%

                      • 0.92

                      • Vanguard Group, Inc.

                      •  

                        4,200

                      • 0.00%

                      • 0.03

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Instruments & Supplies

                      Type

                      Speculative Growth

                      Style

                      Small Growth

                      BioLife Solutions Inc was originally incorporated in Delaware in 1987 under the name Trans Time Medical Products, Inc. In 2002, the Company, then called Cryomedical Sciences, Inc. completed a merger with its wholly-owned subsidiary, ...moreBioLife Solutions, Inc. Following the merger, the Company changed its name to BioLife Solutions, Inc. The Company develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells and tissues. The Companys product offerings include: patented biopreservation media products for cells, tissues, and organs; generic formulations of blood stem cell freezing media products; custom product formulation and custom packaging services; and contract aseptic manufacturing formulation, fill, and finish services of liquid media products; precision ...morethermal packaging products. Its sales and marketing strategy supports its objective of building equity in BioLife Solutions as the brand that manufactures and delivers cGMP, serum-free, protein-free, biopreservation media products for cells, tissues, and organs. Currently, the Company has four issued U.S. patents, one issued European patent, one issued Japanese patent, and several pending international patent applications. The markets for its products are competitive and are characterized by the application of advanced technologies. Its competition comes from larger manufacturers such as Life Technologies Corp. (formally Invitrogen), and distributors including STEMCELL Technologies, Sigma-Aldrich, VWR, Fisher, and smaller specialized companies.lessless

                      Key People

                      Mr. Michael P. Rice

                      CEO/Director/President

                      Mr Raymond Wayne Cohen

                      Chairman of the Board/Director

                      Ms. Daphne L. Taylor

                      CFO/Chief Accounting Officer/Secretary/Vice President, Divisional

                      Andrew G. Hinson

                      Director

                      Mr. Rick Stewart

                      Director

                      • BioLife Solutions Inc

                      • 3303 Monte Villa Parkway

                      • Bothell, WA 98021

                      • USA.Map

                      • Phone: +1 425 402-1400

                      • Fax: +1 425 402-1433

                      • biolifesolutions.com

                      Incorporated

                      1987

                      Employees

                      23

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: